Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 44 for fetal

Edit search filters
  1. A Study to Evaluate Smartphone-based Fetal Heart Rate Monitor for Self Administration by Low-risk Pregnant Women

    Rochester, MN

  2. A Study to Learn More About the Relationship between Fetal DNA and the Maternal Immune System

    Rochester, MN

  3. A Study of the Relationship Between Fetal (Pre-birth Infant) DNA and the Maternal Immune Response

    Rochester, MN

  4. A Study to Assess Maternal and Fetal Outcomes in Pregnancy with Type 1 Diabetes Mellitus and Controls

    Rochester, MN

  5. Discordance of Umbilical Artery Flow in Intrauterine Growth Restriction of Singleton Gestations

    Rochester, MN

  6. Fetal Cardiac MR Images to Improve the Diagnostic Accuracy of Prenatal Imaging for Congenital Heart Disease

    Rochester, MN

  7. Determining if Biologics for Atopic Diseases During Pregnancy Increased the Risk of Adverse Maternal and Fetal Outcomes

    Rochester, MN

  8. A Study to Identify Rare Versions of Genes Associated with Certain Types of Congenital Malformations (CM)

    Rochester, MN

  9. A Study to Collect Maternal Blood Samples to Isolate DNA for Prenatal Screening (NIPS) in Patients Undergoing Prenatal Chromosomal Testing

    Rochester, MN

  10. A Study to Measure Markers of Immune Tolerance to Predict Women at Risk of Miscarriage or Failed Embryo Transfer

    Rochester, MN

.

Mayo Clinic Footer